CFP, complement factor properdin, 5199

N. diseases: 108; N. variants: 7
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.090 AlteredExpression disease BEFREE Schizophrenia patients typically exhibit prominent negative symptoms associated with deficits in extinction recall and decreased ventromedial prefrontal cortex activity (vmPFC, analogous to medial PFC infralimbic segment in rodents). mPFC activity modulates the activity of basolateral amygdala (BLA) and this connectivity is related to extinction. mPFC and BLA activity has been shown to be altered in the methylazoxymethanol acetate (MAM) developmental disruption model of schizophrenia. 29973655 2018
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.090 Biomarker disease BEFREE Alternative splicing of GAD1 and epigenetic state appear to play roles in the developmental profile of GAD1 expression and may contribute to GABA dysfunction in the PFC and hippocampus of patients with schizophrenia. 28485403 2018
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.090 Biomarker disease BEFREE These findings suggest that interneuron dysfunction may contribute to cognitive deficits associated with schizophrenia by disrupting long-range synchrony between the HPC and PFC. 30318409 2018
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.090 Biomarker disease BEFREE Research in neurotypical individuals has shown that storage capacity is more closely related to posterior parietal cortex (PPC) than PFC, suggesting that reductions in WM storage capacity in schizophrenia that are associated with broad cognitive deficits may be related to neural activity in PPC. 30104335 2018
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.090 Biomarker disease BEFREE Rodent studies report reduced coherence between HC and PFC during anesthesia, sleep and task performance in both genetic, environmental and neurodevelopmental models for schizophrenia. 28089652 2017
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.090 Biomarker disease BEFREE This study used a rat model to test whether prenatal immune activation with lipopolysaccharide (LPS; at gestation days, GD, 15 and 16) or maternal iron deficiency (from GD2 to postnatal day P7) or the combination of both insults alters major subtypes of GABAergic interneurons (parvalbumin, somatostatin, cholecystokinin) in brain regions relevant to schizophrenia (medial and dorsolateral prefrontal cortex [PFC], hippocampal CA1 and dentate gyrus, ventral subiculum) in offspring at P14 or P28. 28214898 2016
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.090 GeneticVariation disease BEFREE We found evidence of alterations in the expression of the initial elements of the TLR4 signalling pathway (TLR4, Myeloid differentiation primary response gene 88 [MyD88] and nuclear factor-κ B [NF-κB]) in the PFC of patients with schizophrenia. 27070349 2016
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.090 Biomarker disease BEFREE Deficits in dopamine transmission at D1 receptors in the PFC are implicated in schizophrenia. 21955727 2011
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.090 Biomarker disease BEFREE We further provided evidence that TBP genotypes with greater than 35 CAG repeats, which were enriched in patients with schizophrenia, were significantly associated with hypoactivation of the prefrontal cortex measured by near-infrared spectroscopy during the tower of Hanoi, a task of executive function (right PFC; p = 0.015, left PFC; p = 0.010). 19566714 2009